This finding not only provides a novel mechanism for studying circ-MBOAT2-based effects on the evolution of pancreatic cancer, but also provides a new potential biomarker for the diagnosis and therapy of pancreatic cancer. The gene discussed is MBOAT2; the disease is pancreatic neoplasm.